A Study of an Existing Database to Assess the Treatment Persistence to Basal Insulin in Type 2 Diabetes Mellitus Patients in a Structured Patient Education Program in India
NCT05628090 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 47885
Last updated 2024-03-08
Summary
The aim of this study is to analyze data from an existing database named SAATH-7 Star, in order to assess the treatment persistence to basal insulin in Type 2 diabetes patients who had been enrolled in the SAATH-7 Star structured patient education program in India.
Conditions
- Type 2 Diabetes Mellitus (T2DM)
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Clinical Sciences & Operations · Sanofi
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-11-30
- Primary Completion
- 2023-12-29
- Completion
- 2023-12-29
Countries
- France
Study Locations
More Related Trials
-
A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered With Metformin to Type 2 Diabetes Patients
NCT02202161 ·Status: COMPLETED ·Phase: PHASE2
-
A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes
NCT00976261 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes
NCT01338870 ·Status: COMPLETED ·Phase: PHASE2
-
To Assess Safety of Fixed Dose Combination of Dapagliflozin and Saxagliptin in Type 2 Diabetes Mellitus Patients
NCT04445714 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045)
NCT00758069 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment With Sitagliptin in Non-obese Japanese Patients With Type 2 Diabetes Mellitus
NCT01642108 ·Status: UNKNOWN ·Phase: NA
-
Using of SGLt2 Inhibitors in Patients With Type 2 DM
NCT06268977 ·Status: NOT_YET_RECRUITING
-
Phenotypic and Genetic Correlates of Diabetes (Non-Type 1) in Young Non-Obese Asian Indians in North India and A Study to Evaluate the Efficacy of Sitagliptin (DPP-4 Inhibitor) in a Sub-group of the Study Population
NCT00964184 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise (0431-158)
NCT00832390 ·Status: COMPLETED ·Phase: PHASE4
-
Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery
NCT02556918 ·Status: COMPLETED ·Phase: PHASE4
-
Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus
NCT00337610 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
NCT02025907 ·Status: COMPLETED ·Phase: PHASE4
-
A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin
NCT02551874 ·Status: COMPLETED ·Phase: PHASE3
-
Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With T2DM
NCT00820573 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients
NCT00751114 ·Status: COMPLETED ·Phase: PHASE4
-
Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes
NCT01260246 ·Status: TERMINATED ·Phase: NA
-
Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus
NCT00762112 ·Status: TERMINATED ·Phase: PHASE3
-
Empagliflozin-based Quadruple Therapy vs Basal Insulin-based Therapy
NCT05103306 ·Status: UNKNOWN
-
Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059)
NCT00704132 ·Status: COMPLETED ·Phase: PHASE1
-
Glucagon-like Peptide-1 Levels, Insulin Resistance and Insulin Sensitivity Index in Type 2 Diabetes Mellitus
NCT03659461 ·Status: COMPLETED ·Phase: NA
-
A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin
NCT00734474 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061)
NCT00511108 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic Therapy
NCT03700801 ·Status: COMPLETED ·Phase: PHASE4
-
Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus
NCT01336738 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Different Early Intensive Therapies on Long-term β-cell Function
NCT01471808 ·Status: COMPLETED ·Phase: PHASE4